Welichem Biotech Inc. Announces Appointment of President & CEO
Dr. John Webster, Interim Chairman of the Company, stated that "He was very pleased that Dr. Chen had agreed to take up the key leadership role at Welichem at this time. He has a deep understanding of both the business and scientific components of the Company and related international experience in the biotech industry. His commitment and insight will be invaluable."
York Yingping Guo resigned as President & CEO for personal and family reasons. Dr. Webster opined that "Welichem Biotech has been very fortunate to have had York as its President and CEO. The Company has achieved significant milestones during his tenure and I am very grateful for the great contribution he has made to the Company."
About Welichem Biotech Inc.
Welichem Biotech Inc. is a publicly-traded biotechnology company developing therapeutic drugs in the fields of autoimmune and inflammatory diseases and cancer.
ON BEHALF OF THE BOARD John M. Webster Interim Chairman of Board of Directors
For further information
John M. Webster, Tel.: (604) 432-1703, Email: info@welichem.com Yan Chen, Business Development Manager, Tel.: (604) 432-1703, Email: investors@welichem.com
Source: Welichem Biotech Inc.